News, Deals & Cases

On 16 March 2026, UBS AG, acting through its Stamford branch issued USD 500 million in aggregate principal amount of Floating Rate Senior Notes due 2029, USD 1.3 billion in aggregate principal amount of 4.302% Senior Notes due 2029, and USD 1.25 billion in aggregate principal amount of 4.632% Senior Notes due 2032. The notes were offered and sold in reliance on an exemption from registration provided by the U.S. Securities Act.

On 16 March 2026, CRISPR Therapeutics AG issued a USD 600 million aggregate principal amount of convertible senior notes with a semiannual effective coupon of 1.7308% due 2031

On 16 March 2 On 15 April 2026, Sandoz Group AG issued CHF 275 million 1.1875% fixed rate bonds due 2032 and CHF 275 million 1.55% fixed rate bonds due 2036.

On 5 March 2026, Swiss Prime Site issued CHF 350 million senior unsecured  green convertible bonds due 2032. These convertible bonds are convertible into registered shares of Swiss Prime Site. BNP Paribas, Goldman Sachs International and UBS served as joint bookrunners in the transaction.

On 2 March 2026, Zurich Insurance Group initiated an accelerated bookbuilding offering, which led to the placement of 7,090,909 newly issued shares at an offer price of CHF 550.00 each, and raising aggregate gross proceeds of approximately USD 5.0 billion. The net proceeds from the capital increase will be directed at partly financing Zurich‘s acquisition of Beazley. The new shares are listed on SIX Swiss Exchange. Goldman Sachs, Morgan Stanley and UBS acted as Joint Global Coordinators and Bookrunners, Citigroup and Deutsche Bank acted as Joint Bookrunners, and Crédit Agricole and Zürcher Kantonalbank acted as Co-Lead Managers in the offering.

On 6 January 2026, Ultima Capital SA issued a CHF 100 m common bond loan subscribed for by National Bank of Greece S.A.

On 7 January 2026, PLAZZA AG placed a fixed-rate bond of CHF 100 million with a coupon of 1.25% and a term of 5.2 years, maturing on 31 March 2031. The proceeds will be used to refinance bank loans and to finance development and renovation projects. UBS, Zürcher Kantonalbank and Luzerner Kantonalbank coordinated the placement as Joint Lead Managers. The bonds are admitted for trading on SIX Swiss Exchange.

On 8 January 2026, UBS Group AG issued USD 1.5 billion 6.625% Tier 1 Capital Notes and USD 1.5 billion 7.0% Tier 1 Capital Notes.

On 13 January 2026, Swiss Life issued CHF 225m subordinated bonds, first callable in January 2032. The bonds were placed with investors in the Swiss Franc market. The bonds will be listed on SIX Swiss Exchange.